Lepu Medical's Subsidiary Receives NMPA Approval for MemoSorb® Biodegradable Atrial Septal Defect Occluder

Yicai Global APP reported that Lepu Medical (300003.SZ) announced today that its subsidiary, Shanghai Shape Memory Alloy Co., Ltd., has officially received registration approval from the National Medical Products Administration (NMPA) for its independently developed MemoSorb® Bioresorbable Atrial Septal Defect Occluder. The medical device registration number is: NMPA Approval No. 20243131488. This product is used for occlusion treatment of secondary hole type atrial septal defect (ASD) in congenital heart disease.